Showing results (41-50 of 77) with videos related to
Sort By:
Pageof 8
Cancer Research|June 1, 1986
Selective modulation by alpha-difluoromethylornithine of T-lymphocyte and antibody-mediated cytotoxic responses to mouse tumor allograftsM J Ehrke, C W Porter, C Eppolito, et al.Journal of Immunopharmacology|January 1, 1980
Modification of mouse immune responses against allogeneic tumor by pretreatment of antigen with mitomycin C or X-irradiationC C Hoffmann, M J Ehrke, G Papp, et al.Immunopharmacology|February 1, 1982
Human prealbumin fraction: effects on cell-mediated immunity and tumor rejectionK H Leung, M J Ehrke, K Bercsenyi, et al.International Archives of Allergy and Immunology|January 1, 1993
Polymyxin B-mediated lysis of tumor cellsS Verstovsek, D L Maccubbin, M J Ehrke, et al.Cancer Research|June 1, 1978
Cell population kinetics of fast- and slow-growing transplantable tumors derived from spontaneous mammary tumors of the DBA/2 Ha-DD mouseZ P Pavelic, C W Porter, L M Allen, et al.Lymphokine and Cytokine Research|April 1, 1994
TNF-alpha potentiation of the lymphokine-activated killer response of murine thymus cellsP Ujházy, D Maccubbin, C Eppolito, et al.International Journal of Immunopharmacology|January 1, 1987
Low concentrations of thymidine modulate allogeneic responsesL Strzadala, D Maccubbin, K Ryoyama, et al.Molecular Pharmacology|November 1, 1994
Doxorubicin-induced DNA degradation in murine thymocytesG Zaleskis, E Berleth, S Verstovsek, et al.Cancer Research|August 1, 1989
Modification of host antitumor defense mechanisms in mice by progressively growing tumorD L Maccubbin, K F Mace, M J Ehrke, et al.International Journal of Immunopharmacology|January 1, 1983
Adriamycin induced immunomodulation: dependence upon time of administrationM J Ehrke, V Tomazic, K Ryoyama, et al.Pageof 8